相关实验视频

Updated: Jun 14, 2025

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

在 Mycobacterium 结核综合体中解码耐药性:遗传洞察力和未来的挑战

Amey Deshpande^1,2, Rupali Likhar^1,3, Tabassum Khan¹

¹Department of Pharmaceutical Chemistry, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, India.

Expert review of anti-infective therapy

|September 2, 2024

概括

耐药结核病 (TB) 是一个全球性卫生挑战. 本综述涵盖了结核病耐药性机制,如全基因组测序等诊断,以及有效的全球控制策略.

科学领域:

微生物学微生物学
遗传学是一个遗传学.
公共卫生公共卫生

背景情况:

结核病 (TB),包括多耐药结核病 (MDR-TB) 和广泛耐药结核病 (XDR-TB),仍然是一个关键的全球卫生问题.
尽管治疗和诊断方面取得了进展,但 * Mycobacterium tuberculosis * (MTB) 耐药性的日益复杂性阻碍了根除努力.

研究的目的:

审查抗结核病药物耐药性的复杂性,包括其遗传机制.
探索先进的诊断技术及其对治疗耐药结核病的影响.
讨论当前的治疗策略,挑战,全球差异以及未来的研究方向.

主要方法:

对抗一线和二线抗结核药物耐药性的遗传基础的审查.
探索先进的诊断技术,如全基因组测序 (WGS) 和基于CRISPR的诊断.
讨论人工智能应用,治疗策略和全球健康差异.

主要成果:

关键基因的突变是抗结核药物耐药性的遗传基础的核心.
先进的诊断技术,包括WGS和CRISPR,可以更好地识别和管理耐药结核病.
人工智能应用和个性化医疗方法显示了彻底改变结核病管理的潜力.

结论:

结合先进诊断,新疗法和全球合作的综合方法对于打击抗结核病药物耐药性至关重要.
未来的研究应该集中在多基因耐药性和个性化医学上.
公平地获得诊断和治疗,以及充足的资金,对于有效的结核病控制至关重要.

关键词:

结核病菌菌菌的结核病菌的结核病菌.治疗和控制XDR-TB的治疗和控制.药物耐药性耐药性药物耐药性广泛耐药结核病 (XDR-TB) 是一种广泛耐药性结核病.遗传突变基因突变全基因组测序 (WGS) 是一种全基因组测序.

更多相关视频

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Antibiotic Selection

Antibiotic Selection

Defense Against Bacterial Pathogens

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...